Homœopathic Links 2023; 36(01): 049-057
DOI: 10.1055/s-0042-1758218
Case Report

Post-COVID-19 Inappropriate Sinus Tachycardia Treated with Naja tripudians: A Case Report

Amit Arora
1   Chief Medical Officer (NFSG) (Homoeopathy), Health and Family Welfare Directorate, Directorate of AYUSH, Government of National Capital Territory of Delhi, New Delhi, India
,
Udesh Kumar
1   Chief Medical Officer (NFSG) (Homoeopathy), Health and Family Welfare Directorate, Directorate of AYUSH, Government of National Capital Territory of Delhi, New Delhi, India
,
Dhananjay Kumar Shukla
2   Nehru Homeopathic Medical College and Hospital, Government of National Capital Territory of Delhi, New Delhi, India
› Author Affiliations

Abstract

Background/Introduction The majority of people who recover from coronavirus disease 2019 (COVID-19) experience tachycardia and/or palpitations after slight activity or at rest. In some cases, the resting heart rate may remain above 100 beats per minute or get exacerbated out of proportion by slight activity. This persistent tachycardia appearing in post-COVID-19 may clinically present as inappropriate sinus tachycardia (IST). The common mode of diagnosis is electrocardiography after excluding other causes of tachycardia. So far, there is no reported study evaluating individualised homoeopathic intervention in post-COVID-19 IST in peer-reviewed homoeopathic journals.

Method This report describes a case of tachycardia and palpitations developed after COVID-19. After complete evaluation of laboratory reports and clinical examination, the diagnosis of IST was made. After detailed case taking and repertorisation, Naja tripudians was prescribed as an individualised homoeopathic remedy to treat the case. Outcomes were assessed objectively on the basis of electrocardiography and subjectively using outcome related to impact on daily living (ORIDL) scale.

Result There was a marked subjective improvement along with objective improvement as evidenced by electrocardiography images. The case showed a 4+ outcome on ORIDL scale. The Modified Naranjo Criteria total score was +9 out of a possible +13, providing definite evidence to attribute the clinical outcome with the homoeopathic intervention.

Conclusion This single case demonstrates that Naja tripudians, a rarely used drug, may be helpful in treating post-COVID-19 IST. Clinical trials in this direction are required to conclude firm causal attribution.

Consent

The patient gave informed consent to have his case published.


Authors' Contributions

A.A. was involved in case recording, case diagnosis, literature research, appropriate remedy selection for case and drafting the paper; U.K. contributed to opinion regarding investigations, opinion regarding appropriate remedy selection for case, drafting the paper; D.K.S. provided opinion regarding investigations, drafting the paper.




Publication History

Article published online:
31 March 2023

© 2023. Thieme. All rights reserved.

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India